相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Satin therapy increases lipoprotein(a) levels
Sotirios Tsimikas et al.
EUROPEAN HEART JOURNAL (2020)
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Francois Mach et al.
EUROPEAN HEART JOURNAL (2020)
Interpretation and Potential Biases of Mendelian Randomization Estimates With Time-Varying Exposures
Jeremy A. Labrecque et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2019)
Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease
Brian A. Ference et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Mendelian randomization analysis using mixture models for robust and efficient estimation of causal effects
Guanghao Qi et al.
NATURE COMMUNICATIONS (2019)
Systolic Blood Pressure and Risk of Valvular Heart Disease: A Mendelian Randomization Study
Milad Nazarzadeh et al.
JAMA CARDIOLOGY (2019)
An examination of multivariable Mendelian randomization in the single-sample and two-sample summary data settings
Eleanor Sanderson et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2019)
Calcific aortic valve stenosis: hard disease in the heart
Frederique E. C. M. Peeters et al.
EUROPEAN HEART JOURNAL (2018)
Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases
Marie Verbanck et al.
NATURE GENETICS (2018)
Beneficial Effects of High-Density Lipoproteins on Acquired von Willebrand Syndrome in Aortic Valve Stenosis
C. Gebhard et al.
THROMBOSIS AND HAEMOSTASIS (2018)
The MR-Base platform supports systematic causal inference across the human phenome
Gibran Hemani et al.
ELIFE (2018)
The UK Biobank resource with deep phenotyping and genomic data
Clare Bycroft et al.
NATURE (2018)
Sensitivity Analyses for Robust Causal Inference from Mendelian Randomization Analyses with Multiple Genetic Variants
Stephen Burgess et al.
EPIDEMIOLOGY (2017)
2017 ESC/EACTS Guidelines for the management of valvular heart disease The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)
Helmut Baumgartner et al.
EUROPEAN HEART JOURNAL (2017)
Epidemiology of valvular heart disease in a Swedish nationwide hospital-based register study
Pontus Andell et al.
HEART (2017)
MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data
Olena O. Yavorska et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2017)
Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption
Fernando Pires Hartwig et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2017)
Association Between Cardiovascular Risk Factors and Aortic Stenosis The CANHEART Aortic Stenosis Study
Andrew T. Yan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease
A. Michael Lincoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Global, Regional, and National Burden of Rheumatic Heart Disease, 1990-2015
David A. Watkins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
The modern epidemiology of heart valve disease
Sean Coffey et al.
HEART (2016)
Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator
Jack Bowden et al.
GENETIC EPIDEMIOLOGY (2016)
Commentary: Two-sample Mendelian randomization: opportunities and challenges
Debbie A. Lawlor
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2016)
Two-sample Mendelian randomization: avoiding the downsides of a powerful, widely applicable but potentially fallible technique
Fernando Pires Hartwig et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2016)
Association of Lipid Fractions With Risks for Coronary Artery Disease and Diabetes
Jon White et al.
JAMA CARDIOLOGY (2016)
Multivariable Mendelian Randomization: The Use of Pleiotropic Genetic Variants to Estimate Causal Effects
Stephen Burgess et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2015)
Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression
Jack Bowden et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2015)
UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age
Cathie Sudlow et al.
PLOS MEDICINE (2015)
Mendelian randomization in health research: Using appropriate genetic variants and avoiding biased estimates
Amy E. Taylor et al.
ECONOMICS & HUMAN BIOLOGY (2014)
Methodological Challenges in Mendelian Randomization
Tyler J. VanderWeele et al.
EPIDEMIOLOGY (2014)
Association of Low-Density Lipoprotein Cholesterol-Related Genetic Variants With Aortic Valve Calcium and Incident Aortic Stenosis
J. Gustav Smith et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk
Timothy A. Fairbairn et al.
HEART (2013)
Calculating statistical power in Mendelian randomization studies
Marie-Jo A. Brion et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2013)
Discovery and refinement of loci associated with lipid levels
Cristen J. Willer et al.
NATURE GENETICS (2013)
Genetic Associations with Valvular Calcification and Aortic Stenosis
George Thanassoulis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
Gregory G. Schwartz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease
Heribert Schunkert et al.
NATURE GENETICS (2011)
Effect of Lipid Lowering With Rosuvastatin on Progression of Aortic Stenosis Results of the Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) Trial
Kwan Leung Chan et al.
CIRCULATION (2010)
Nonrheumatic calcific aortic stenosis: an overview from basic science to pharmacological prevention
Alessandro Parolari et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2009)
Prognosis and risk factors in patients with asymptomatic aortic stenosis and their modulation by atorvastatin (20 mg)
Wolfgang Dichtl et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis
Anne B. Rossebo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Triglycerides and the risk of coronary heart disease - 10 158 incident cases among 262 525 participants in 29 Western prospective studies
Nadeem Sarwar et al.
CIRCULATION (2007)
Burden of valvular heart diseases: a population-based study
Vuyisile T. Nkomo et al.
LANCET (2006)
A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis
SJ Cowell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Atherosclerosis-like lesions of the aortic valve are common in adults of all ages:: a necropsy study
J Kuusisto et al.
HEART (2005)
'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?
GD Smith et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2003)
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial
R Collins et al.
LANCET (2002)
分享论文
